BNT314
mAbexperimentalBi-specific
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2023 (NCT06150183)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- Yes (Bi-specific)
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07079631 | Phase 1/Phase 2 (Phase 2) | Jul 18, 2025 | Biontech, Genmab |
| NCT06150183 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2023 | Biontech, Genmab |
Showing 2 of 2 trials
Page 1 / 1